ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

ZLAB Zai Lab Ltd

19,93
-0,92 (-4,41%)
16 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Zai Lab Ltd ZLAB NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,92 -4,41% 19,93 20:28:02
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
20,39 19,42 20,39 19,93 20,85
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/05/202408:30BWZai Lab Announces Participation in May and June Investor..
14/05/202408:30BWZai Lab Announces Acceptance of Supplemental Biologics..
12/05/202421:20BWZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for..
08/05/202417:05BWZai Lab Announces First Quarter 2024 Financial Results and..
15/04/202408:30BWZai Lab to Announce First Quarter 2024 Financial Results and..
11/04/202408:30BWZai Lab Statement on Executive Management Team’s Agreement..
02/04/202408:30BWZai Lab Presentations at AACR 2024 Annual Meeting to..
01/04/202408:30BWZai Lab Partner Bristol Myers Squibb Announces Pivotal..
27/03/202410:29BWZai Lab Partner Novocure Announces METIS Phase 3 Clinical..
13/03/202420:05BWZai Lab to Present Data Highlighting ZL-1310, a Novel..
06/03/202418:01BWZai Lab to Present Final Overall Survival (OS) Data from..
06/03/202409:30BWZai Lab Announces Participation in March Investor Conference
27/02/202418:05BWZai Lab Announces Full-Year 2023 Financial Results and..
25/01/202418:15BWZai Lab to Announce Full-Year 2023 Financial Results and..
10/01/202419:12BWZai Lab Announces The New England Journal of Medicine..
19/12/202309:30BWZai Lab Announces Participation in January Investor..
13/12/202310:53GLOBEParatek Pharmaceuticals Announces Inclusion of Oral NUZYRA®..
13/12/202301:10BWZai Lab Announces the First Listing of VYVGART®..
07/11/202318:05GLOBEZai Lab Announces Third Quarter 2023 Financial Results and..
26/10/202308:30GLOBEZai Lab Announces Participation in November Investor..
18/10/202308:30GLOBEZai Lab to Announce Third Quarter 2023 Financial Results and..
18/09/202308:30GLOBEZai Lab Obtains Breakthrough Therapy Designation for..
30/08/202308:30GLOBEZai Lab Announces Breakthrough Therapy Designation Granted..
29/08/202308:38GLOBEZai Lab Announces Participation in September Investor..
07/08/202317:05GLOBEZai Lab Announces Second Quarter 2023 Financial Results and..
20/07/202308:30GLOBEZai Lab to Announce Second Quarter 2023 Financial Results..
19/07/202308:30GLOBEJAMA Oncology Publishes Data from Zai Lab Study..
17/07/202312:04DJNArgenx Shares Hit 52-Week High After Positive Vyvgart..
17/07/202308:10DJNArgenx, Zai Lab Shares Rise After Positive Trial Results for..
17/07/202302:03GLOBEZai Lab and argenx Report Positive Topline Data from ADHERE..
14/07/202308:30GLOBEZai Lab Announces First Patient Treated in Mainland China..
10/07/202308:30GLOBEZai Lab Announces Acceptance by China’s NMPA of the BLA for..
06/07/202317:05GLOBEZai Lab Announces Promotion of Yajing Chen to Chief..
30/06/202310:22GLOBEZai Lab and argenx Announce Approval of VYVGART®..
28/06/202308:30GLOBEZai Lab Announces NDA Acceptance of Repotrectinib for..
23/06/202306:45PRNUSZLAB FRAUD ALERT: Jakubowitz Law is Investigating Zai Lab..
21/06/202306:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
12/06/202322:36PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
12/06/202321:45PRNUSZLAB FRAUD ALERT: Jakubowitz Law is Investigating Zai Lab..
06/06/202309:05GLOBEZai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial..
01/06/202317:03GLOBEZai Lab to Highlight New Data from its Oncology Pipeline at..
25/05/202308:30GLOBEZai Lab Announces Participation in June Investor Conferences
18/05/202308:30GLOBEZai Lab Announces That Repotrectinib Granted Priority Review..

Seu Histórico Recente